Show items per page
Elements: 2
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results Zilli, Thomas; Jorcano, Sandra; Bral, Samuel; Rubio, Carmen; ... Miralbell, Raymond 2020
add to browser selection
Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter? Achard, Verane; Jorcano, Sandra; Rouzaud, Michel; Escudé, Lluís; ... Zilli, Thomas 2019